Walters Group

Walters Group is listed in filings as 10% Owner at Zentalis Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 8, 2026, including purchase activity. Recent filings connect the profile to Zentalis Pharmaceuticals, Inc. (ZNTL). The current snapshot covers public activity from Jan 8, 2026. Reported amounts are shown as $7.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.